Clearing up potential misconceptions about the treatment of rheumatoid arthritis and the use of methotrexate in combination therapy

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Canadian Pharmacists Journal / Revue des Pharmaciens du Canada

• Publication date

  2018-02-09

• Fields of study

  Medicine

• Identifiers
  DOI 10.1177/1715163518756679PMID 29531625PMCID PMC5843120
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Efficacy of glucocorticoids, conventional and targeted synthetic disease-modifying antirheumatic drugs: a systematic literature review informing the 2016 update of the EULAR recommendations for the management of rheumatoid arthritis

  2017cited by this paper
• Interaction Between Low-Dose Methotrexate and Nonsteroidal Anti-inflammatory Drugs, Penicillins, and Proton Pump Inhibitors

  2017cited by this paper
• Efficacy of biological disease-modifying antirheumatic drugs: a systematic literature review informing the 2016 update of the EULAR recommendations for the management of rheumatoid arthritis

  2017cited by this paper
• Comparative Risk of Harm Associated With the Use of Targeted Immunomodulators: A Systematic Review

  2016cited by this paper
• Methotrexate monotherapy and methotrexate combination therapy with traditional and biologic disease modifying anti-rheumatic drugs for rheumatoid arthritis: A network meta-analysis.

  2016cited by this paper
• 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis

  2016cited by this paper
• Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force

  2015cited by this paper
• Evidence for treating rheumatoid arthritis to target: results of a systematic literature search update

  2015cited by this paper
• Communicating across cultures: proceedings of a workshop to assess health literacy and cross‐cultural communication skills

  2015cited by this paper
• Efficacy and safety of tofacitinib following inadequate response to conventional synthetic or biological disease-modifying antirheumatic drugs

  2015cited by this paper
• Practice guidelines for pharmacists

  2014cited by this paper
• Update on methotrexate as the anchor drug for rheumatoid arthritis.

  2013cited by this paper
• The role of DMARDs in reducing the immunogenicity of TNF inhibitors in chronic inflammatory diseases

  2013cited by this paper
• Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial.

  2013cited by this paper
• Canadian Rheumatology Association Recommendations for Pharmacological Management of Rheumatoid Arthritis with Traditional and Biologic Disease-modifying Antirheumatic Drugs

  2012cited by this paper
• 2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease‐modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis

  2012cited by this paper
• State-of-the-art: rheumatoid arthritis

  2010cited by this paper
• EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update

  2010cited by this paper
• Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in patients with early rheumatoid arthritis (Swefot trial): 1-year results of a randomised trial.

  2009cited by this paper
• A large-scale validation study of the Medication Adherence Rating Scale (MARS).

  2008cited by this paper
• Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial.

  2005cited by this paper
• Measuring compliance with drug regimens after renal transplantation: comparison of self-report and clinician rating with electronic monitoring

  2004cited by this paper
• Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial.

  2004cited by this paper
• The compliance-questionnaire-rheumatology compared with electronic medication event monitoring: a validation study.

  2003cited by this paper
• Development of a questionnaire to investigate patient compliance with antirheumatic drug therapy.

  1999cited by this paper
• Concurrent and Predictive Validity of a Self-reported Measure of Medication Adherence

  1986cited by this paper
• Culture, Illness, and Care: Clinical Lessons from Anthropologic and Cross-Cultural Research

  1978cited by this paper
• Culture, illness, and care: clinical lessons from anthropologic and cross-cultural research.

  1978cited by this paper

• Vaccines prevent reinduction of rheumatoid arthritis symptoms in collagen-induced arthritis mouse model

  2023cites this paper